News & Media

Four Manitoba Companies Receive Funding for COVID-19 Research

May 3, 2021 - Research Manitoba is investing and leveraging more than a half-million dollars to support the provincial COVID-19 response by championing local industry-academic research partnerships.

Research Manitoba’s $361,442 investment will support four COVID-19 Innovation Proof-of-Concept grants, as well as leverage $165,000 from other sources to provide a total of $525,442 to support this vital work. T

his support for four innovative Manitoba-based companies will create opportunities for employment and talent development, industrial research and technology collaborations to advance virtual lifestyle programming, COVID-19 testing, personal protective equipment (PPE), and infection prevention.

  1. Chronic Disease Innovation Centre (CDIC)/Fusion Group/ Wellness Institute/University of Manitoba, $99,892 Leveraged funds from industry: $25,000 Can virtual lifestyle programming limit collateral health damage from the COVID-19 pandemic: a pilot study
  2. Intrinsic Analytics Inc./St. Boniface Research Centre/University of Manitoba, $75,000 Leveraged funds from industry: $25,000 Evaluation of a Novel Saliva Based Test for Detection of SARS-CoV-2
  3. Protective Textiles International (PTEX)/St. Boniface Research Centre/University of Manitoba, $100,000 Leveraged funds from industry: $25,000 Copper-Infused Reusable Protective Face Mask for Prevention of SARS-CoV-2 Infections
  4. utR Biotech/University of Manitoba, $86,550 Leveraged funds from industry & Mitacs: $90,000 Development and characterization of utRAP technology - a nanoparticle platform for preventing SARS-Cov2 infection in airway and vasculature



Latest News

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.